We publish below our response to the call for written evidence from the Independent Reviewer of Drugs, Dame Carol Black. The review has two parts, with the first focusing on the demographics of drug use and the features of drug markets. The call for written evidence is part of this first part.
We cover many questions posed by the reviewer, including:
- What are the harms to individuals, families and communities resulting from drug use (including physical, mental, social and economic)?
- What are the barriers to receiving effective treatment in the UK? How might they be overcome?
- What policy changes or improvements do you think would have the biggest impact on reducing the harm from drug use and/or supply?
Related Content
Collective Voice to hold webinar to share challenges and promising practice in supporting people who use ketamine
Raising awareness isn’t enough. We know there are still challenges with making sure the right kind of support is accessible and genuinely addresses the full
Work with Collective Voice to review our approach to lived and living experience
We believe Collective Voice has a key role to play in ensuring treatment is accessible and delivers positive outcomes for everyone who needs it. But
Introducing: The New Collective Voice Affected Others Group!
Adfam and Collective Voice are excited to announce the launch of a brand-new group, bringing together organisations supporting families affected by substance use and individuals with lived experience, to work together to improve support for affected others.
